2019 National Conference Program

The pharmacy benefit management landscape is constantly changing. When you attend PBMI's National Conference, we can help you get up to speed on the latest and best practices for managing the drug benefit!

Attendees have four tracks to choose from and customize their conference learning experience:
Track 1 - Contracting & Industry Relations
Track 2 - Innovation & Technology
Track 3 - Clinical & Trend Management
Track 4 - Designing the Drug Benefit

See below for a list of sessions.

Keynote Speaker
(sponsored by MaxorPlus)

Thomas E. Price MD, 23rd Secretary of Health and Human Services (HHS)
Monday, 1:15 pm - 2:15 pm


Wall Street's Outlook on the PBM Industry

George Hill Managing Director, Healthcare Technology & Distribution Equity Research, RBC Capital Markets
Monday, 2:15 pm - 3:15 pm


Journey of a Specialty Patient (panel)

Physician Executive Medical Director, Schapiro Center for Multiple Sclerosis, Minneapolis Clinic of Neurology
Gina Murdoch Chief Executive Officer, Multiple Sclerosis Association of America (MSAA)
MS Patient
Monday, 4:45 pm - 5:35 pm


An Inside Look Into Cystic Fibrosis: A Patient/Advocate Perspective

Stacy Carmona Director of Cystic Fibrosis, Patient Advocacy, Kroger Specialty Pharmacy
Monday, 5:35 pm - 6:00 pm


The U.S. Pharmaceutical Market: Trends, Issues, and Outlook

Doug Long Vice President Industry Relations, IQVIA
Tuesday, 8:15 am - 9:00 am


Prescription Opioid Vigilance: Perspectives from a Patient, Prescriber, Pharmacist, and Attorney

Jonathan P. Novak Esq., former attorney for the United States Department of Justice Drug Enforcement Administration
Robert Riley II CADC, Co-Founder The Missouri Network for Opiate Reform and Recovery, Co-Founder Rebel Recovery Florida, Co-Founder The Missouri SAFE Project
Christian Rutland MD, Betty Ford Addiction Psychiatry Specialist
Genevieve Regal PharmD, HC-MBA, Clinical Consultant, Confidio
Moderator: Sonja Quale PharmD, Chief Clinical Officer & Vice President, Confidio
Tuesday, 9:00 am - 10:00 am


Highlights From the Last 12 Months in Value-Based Drug Pricing, and What's Next?

Steven D. Pearson MD, MSc, President, Institute for Clinical Economic Review
Tuesday, 3:30 pm - 4:30 pm


Healthcare 2025: A Radically Different Landscape?

Deneen Vojta MD, Executive Vice President, Global Research & Development, UnitedHealth Group
Tuesday, 4:30 pm - 5:30 pm


No content found

No content found

No content found

No content found